Fludrocortisone Acetate

醋酸氟氢可的松

Report date: 2026/04/03 20:03:44

Base Information

Drug NameFludrocortisone Acetate
Drug Alias Namefludrocortisona醋酸氟氢考的松fludrocortisonefludrocortisonum赋能定 +[8] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionMineralocorticoid receptor agonistsGlucocorticoid receptor agonists
TargetsGlucocorticoid receptorMineralocorticoid receptor
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)DepressionCritical Illness +[16] 
Global Approved IndicationsAddison DiseasePruritusEczema +[6] 
Approved Indications in ChinaPruritusEczemaDermatitis, Seborrheic +[4] 
Original Approved Country/TerritoryCanada
Original Approved Date1954/10/28
Country/TerritoryCanadaUnited StatesNetherlands +[9] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAspen Pharmacare Holdings Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSandozChinese University Of Hong Kong (Cuhk)Casper Pharma Llc +[7] 
Inactive CompaniesOregon Health And Science UniversityLeiden University Medical Center
Active IndicationsCoronavirus Disease 2019 (COVID-19)Critical IllnessAddison Disease +[12] 
Inactive IndicationsDepressionHypoadrenocorticism, FamilialAdrenogenital Syndrome +[4] 

Other Information

ATC CodeH02AA02
Related LinksWikipediaDrugBankKEGG